Trademarkia Logo

Canada

C$
TELIX PHARMACEUTICALS
REGISTERED

on 4 Aug 2021

Last Applicant/ Owned by

TELIX PHARMACEUTICALS LIMITED

Suite 226, 55 Flemington RoadNorth Melbourne VIC 3051

AU

Serial Number

1840076 filed on 31st May 2017

Registration Number

TMA1106096 registered on 4th Aug 2021

Registration expiry Date

4th Aug 2031

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

TELIX PHARMACEUTICALS

Trademark usage description

chemicals for pharmaceutical use, namely, chemical additives for use in the manufacture of pharmaceuticals pharmaceutical drugs for the treatment of Read More

Classification Information


Class [001]
Chemicals for pharmaceutical use, namely, chemical additives for use in the manufacture of pharmaceuticals


Classification kind code

11

Class [005]
Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations for the treatment and diagnosis of cancer; Radiopharmaceutical products, namely, radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes, none of the aforementioned for use in the treatment, prevention or diagnosis of central nervous system diseases and disorders


Classification kind code

11

Class [010]
Apparatus for administering pharmaceuticals, namely, injection needles and syringes used to facilitate the diagnosis and treatment of cancer; Apparatus for medical purposes, namely, injection needles and injection syringes, radiological equipment; Apparatus for the treatment of cancer, namely, linear accelerator; Diagnostic imaging apparatus for medical use, namely, magnetic resonance imaging diagnostic apparatus; Pharmaceutical instruments, namely, applicators for the delivery of radiopharmaceuticals used in the diagnosis and treatment of cancer; Applicators for pharmaceutical preparations, namely, inhaler and injector to deliver medication in the diagnosis and treatment of cancer


Classification kind code

11

Class [035]
Advertising the goods and services of others; Business advisory services relating to product development; Business consultancy, namely, business management consultancy; Retail and wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Intermediary business services relating to the commercialisation of goods, namely, procuring of contracts for third parties for the purchase and sale of goods


Classification kind code

11

Class [042]
Provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; Scientific and technical analysis, namely, medical analysis services for cancer diagnosis and prognosis; Scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science; Scientific research in the fields of biotechnology, pharmaceutical research and development, and genetic science; Scientific research in the field of pharmacy, namely, pharmaceutical research and development; Medical research; Research and development of products, namely, medical apparatus for use in the treatment of cancer; Research relating to pharmaceuticals; Advisory services relating to immunological products, namely, vaccines


Classification kind code

11

Class [045]
Licensing of intellectual property


Classification kind code

11

Mark Details


Serial Number

1840076

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 24th Sept 2020
Approved
Submitted for opposition 15
on 12th Mar 2020
Correspondence Created
Submitted for opposition 12
on 4th Mar 2019
Extension of Time
Submitted for opposition 12
on 21st Dec 2018
Extension of Time
Submitted for opposition 15
on 20th Jun 2018
Correspondence Created
Submitted for opposition 22
on 29th May 2018
Search Recorded
Submitted for opposition 20
on 29th May 2018
Examiner's First Report
Submitted for opposition 31
on 5th Jun 2017
Formalized
Submitted for opposition 1
on 1st Jun 2017
Created
Submitted for opposition 30
on 31st May 2017
Filed